FI CONNECT
GLOBAL
Search
Select Country
LIFE AT FI GROUP
CONTACT
BACK TO TOP
Certifications
Previous slide
Next slide
FI Group UK
@FI Group by EPSA Copyright 2025
Policy Privacy
Term of use
Cookie Policy
Compliance FI Group
FI Group UK
@FI Group by EPSA Copyright 2025
Policy Privacy
Term of use
Cookie Policy
Compliance FI Group
Case Study: FI Group UK Supports Stablepharma’s Successful EIC Accelerator Submission
Help us to share it on
About this publication
Published Date
04-08-2025
Reading Time
7 min.
Author
Dr. Giuseppe Amoroso
Not to be missed
6 days ago
UK R&D Spending Surges in 2025, Led by Pharma and Biotech
a month ago
Britain’s new scale up surge: what the £7 billion package means for CFOs
a month ago
UK Germany quantum funding: the new £14m initiative
a month ago
UK-US pharmaceuticals deal: implications for biotech funding and R&D tax
2 months ago
FI Group UK Moves to 40 Leadenhall Street, London, EC3A 2BJ
All Publications
Related
Posts
5 months ago
R&D Enquiry Success Story – FIMATIX | Protecting R&D Tax Credits
a year ago
How R&D Tax Relief Supports the World’s First Cargo Drone Airline – Dronamics Case Study
a year ago
Securing a £400k Manufacturing Grant for Evove
a year ago
Transforming vaccine accessibility: A case study on the Stablepharma R&D tax relief journey
